Skip to content


Our company uses its proprietary ortholucent technology platform to develop, additive manufacture, and sell orthopedic extremity and trauma implants and instruments.


We partner with busy surgeons with a convenient no-hassle process that helps them develop and better monetize innovative product ideas.


We own a growing portfolio of issued patents and pending patent applications that cover hybrid materials and cost-effective manufacturing.







GLW, Inc. Founded

Research &

CREED FDA 510(k) Approval

FUSIONFRAME FDA 510(k) Approval

ISO13485:2016 Certified

Early Product Release

ARTEMIS FDA 510(k) Approval

APOLLO FDA 510(k) Approval

Innov8ortho Partnership
Sales Distribution

Product Release

MDSAP Certified

Full Market Product Releases

Global Expansion


World-Class Engineering

All startups companies have two enemies, cash burn and time. GLW has assembled a Research & Development (“R&D”) team which can, and has, “hit the ground running” resulting in projects moving faster than what is usual and customary in our industry. We look for ways to maximize speed to market without sacrificing quality or core competency. Our R&D team has the ability to evaluate a product strategy, frame up ideas and prototype concepts (working closely with design surgeons and internal engineering staff to gather feedback and design input), and then implements product solutions quickly and effectively.

Quality Management System

GLW believes that committing assets to the implementation and maintenance of a robust Quality Management System (“QMS”) is the way to “future-proof” our investment in a startup. We are ISO13485:2016 certified and in compliance with FDA 21 CFR part 820 Quality System Regulations with particular focus on: 1) Design Control; 2) Risk Management; 3) Document Control & Records Management; and 4) Supplier Management. Our QMS is overseen by quality, regulatory, and legal professionals with decades of combined experience in medical devices.

Surgeon Centric Design Process

Design surgeons are an integral part of our design and development process. We assemble surgeon design teams specifically to each product and collect design and other product input from them. We identify the risks and concerns that surgeon design teams identify and then work systematically to mitigate those risks and address those concerns one after the next. Design surgeons are invaluable to our business strategy as they are the window into our future customer base. This approach, implementing design surgeon know-how from the start of the development process, is one of the key factors that makes investing in medical devices exciting. Engaging physicians throughout all phases of development, from design concept through prototype development and feasibility, and eventually marketing and educational strategies, allows a GLW startup to provide a laser-focused approach to streamlining the entire process of bringing a product to market. This has vastly improved the speed of development and has shortened the turnaround time of implant design, generation, and manufacture.

From Intellectual Property (“IP”) to Investable Intellectual Portfolio

We are passionate about our IP strategizing. Does the company have the freedom to operate in that field? What licenses might one need from third parties? We don’t waste money filing patent applications that are not essential to our product portfolio strategy. We restrict applications to those inventions that are worthwhile and those territories where there will have determined there will be a market or where we will be manufacturing. At the same time, we do not have tunnel-vision with respect to our IP strategy; we continuously consider and evaluate territories and markets where we might one day want to operate and do not limit ourselves only to those we are in today.

Scalable Manufacturing

A successful product design process must proactively consider and account for what is needed for the end goal of manufacturing. We create functional prototypes using design that contemplates at every juncture the relevant manufacturability practices. Investing in scalable manufacturing processes while reducing implant cost is at the core of GLW business model. Our innovative manufacturing processes do not restrict us in ways that traditional manufacturing currently does. This has given us significant degrees of freedom to allow for innovative designs that have never before been seen in the orthopedic market.

The Value Of Our Network

Engagement with end users is also very important to our product development process. Our team has an extensive collective network in the orthopedic and wider medical device marketplace including physicians, operators in manufacturing companies, and operators in distribution companies. Through our deep network, we can build a vast body of knowledge in a short period of time. Members of GLW have worked diligently to build their relationships within the industry over the course of decades. These relationships make it possible to address and resolve very complex problems simply by making a quick phone call and having an informal conversation with some of the best minds in the industry.

Design Quality Expertise IP Protection Manufacturing Network
(Hover over any sections
of the wheel)
(Click any section
of the wheel)


Collaborate To Create

We are proud of our work with HCPs and have policies to ensure our interactions with HCPs are principled and appropriate. We invest in surgeon entrepreneurs with great ideas and provide them with direction and resources required to start bringing their product visions to life.

Inner Entrepreneur

Because of our unique background and expertise, we are able to develop, and commercialize products with a great amount of confidence and proven talent. We relentlessly support ambitions of all who dare to take on intelligent risk. We refuse to be bound by typical design and manufacturing constraints. Where solutions are not obvious, we maintain the freedom to explore until we find them.


Our Leadership Team

Board of Directors

Vadim Gurevich

President & CEO, Board of Directors

Mr. Gurevich has had an extensive business career with over 20 years of leadership experience in medical technology. He has a documented record of success spanning a broad spectrum of disciplines, including orthopedic trauma, foot & ankle, urogynaecology, general surgery and neurosurgery with extensive M&A, licensing, and post-acquisition integration expertise.

Vadim spent eight years as the President and Chief Executive Officer of Novastep, Inc., a privately-held foot & ankle company and leader in percutaneous bunion market, leading Novastep to a successful acquisition by Enovis Corp. His career encompasses a series of executive and senior decision-making positions at Stryker Orthopaedics, Integra LifeSciences, Synovis Surgical (Baxter BioSurgery), and Gyrus Medical (Olympus). He currently serves on the Board of Directors for GLW, Innov8ortho and Sideline Surgeons.

Axel Cremer

Chief Technology Officer

Mr.Cremer brings over 20 years of product development, design and management experience in the orthopaedics industry. As senior manager and technical leader at Stryker Orthopaedics, he has led the development of T2 IM nails, Hoffmann 3 external fixation, Pelvis Pro and Axsos 3 plating product platforms. Axel is one of the industry’s leading experts in titanium plating technologies, having spearheaded the global development for the Axsos 3 plating system at Stryker. He also directed Stryker’s strategic relationship with the US Department of Defense and led the engineering efforts to design the Hoffmann external fixation system for the military in order to be prepared to treat casualties in an austere environment. Axel holds over 100 patents and was the primary trauma representative for all Stryker US based interdivisional projects. He was involved in multiple business development evaluations for Stryker and acted as the point of contact for trauma surgeons submitting product development ideas to the company.

Garret Mauldin

Sr. Director, R&D United States

Mr. Mauldin brings over 15 years of experience in the orthopaedics industry. Garret has become adept in the start-up environment with two successful companies; Inbone Technologies bought at 7X investment and SI-Bone going to IPO.

He is also one of the industry’s leading experts in total ankle replacements, having developed the innovative Inbone ankle system and responsible for new development with the Salto Talaris and Candence ankles systems.

Experience in other industries including automotive, fiber optics, electronics, automation/robotics, manufacturing and military defense has given him the tools to create innovative and highly successful products in their markets. Garret earned both a BSME and MSME from Texas A&M and has over 20 patents in multiple industries.

Arundhati Radhakrishnan

Director of Quality & Regulatory Affairs

John Haller

Board of Directors

John Haller has extensive experience in Global Supply Chain Management and is currently Chief Quality & Operations Officer at Convatec. He spent 25 years with Stryker Corporation where he held the position of Vice President, Global Supply with responsibility for a team of 12,000 employees located at 43 manufacturing sites around the world. John was a member of the United States Army and left the service with the rank of Captain. He currently serves on the Board of Directors for GLW.

Thomas H. Lee, MD

Board of Directors

Dr. Lee was the founder of Orthopedic Foot and Ankle Center in Columbus, OH. He has been active in education and research with over 70 peer reviewed publications. Dr. Lee served as President of AOFAS (American Orthopaedic Foot & Ankle Society) in 2017-2018. He has worked closely with several extremity companies as a design surgeon. His innovative development work has included partnerships with Wright Medical (sold to Stryker) and Stryker Orthopaedics. He has also been an active co-owner in start up Orthopedic companies including Nexa Corporation (sold to Tornier), Darco Corporation (sold to Wright Medical), Therics Biologics (sold to Theken), Bledsoe Corporation (sold to Breg corporation), and Surgical Care Affiliates (sold to Aetna). Dr. Lee is currently active in hospital and orthopedic development within China, India, and Brazil. He currently serves on the Board of Directors for GLW.

Lowell Weil, Jr., DPM

Board of Directors

Dr. Lowell Weil, Jr. is the Executive Chairman of Balance Health. Largest majority physician-owned podiatric medical organization in the United States. He is a founding partner of Foot and Ankle Business Innovations (FABI), a group focused on increasing physicians practice efficiencies and profitability. With his MBA and extensive management experience, Lowell has been involved with surgical and product innovation for his entire career. As the lead U.S. surgeon consultant for Newdeal Technologies (Newdeal), he helped in getting their products to market, spearheading the relationship between Newdeal and Wright Medical. He played a major role in the evolution of Memometal Technologies (MMI), being a part of the design team and generating IP that created the Anchorage plating system. Lowell pioneered and developed what ultimately became the Complete Plantar Plate System (CPR) by Arthrex and was a member of Treace Medical Systems surgeon advisory board. Dr. Weil, Jr. currently serves on the Board of Directors for GLW and Balance Health.

Keith L. Wapner, MD

Board of Directors

Dr. Wapner was Clinical Professor Orthopedic Surgery, University of Pennsylvania – Chief of the Division of Orthopedic Foot and Ankle Surgery and served as Director of the Orthopaedic Foot and Ankle Fellowship Program. He has published over 100 peer reviewed articles and authored 41 textbook chapters related to Foot and Ankle Surgery. He has been involved in product development for over 20 years and has extensive experience in product evaluations and surgeon education. Dr. Wapner has had numerous positions within the AOFAS (American Orthopaedic Foot & Ankle Society) serving on the Board of Directors of the AOFAS and served as President in 2010-2011. He also served on the Board of Directors of Foot & Ankle International. He currently serves on the Board of Directors for GLW.



Company products are available in the United States via our strategic sales partner Innov8ortho, LLC. Innov8ortho is the US sales distributor of our technology across the country and is a sustainable, competitive, and customer-centric sales organization.

For product inquiries or purchasing questions:
Customer Service